Company
Phio Pharmaceuticals Corp. (PHIO)
Standardized SEC financial data for Phio Pharmaceuticals Corp. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001533040 · NASDAQ · Pharmaceutical Preparations.
Revenue growth (YoY)
-100.0%
Return on equity
-43.2%
Free cash flow
-$8.0M
Debt / equity
0.00×
Current ratio
21.16×
EPS (diluted)
$-9.08
Ratios for fiscal year 2020, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $0 | — | — | — | — | — |
| R&D expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $14.3M | $24.1M | $11.8M | $8.5M | $5.4M | $21.0M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$8.8M | -$11.9M | -$12.1M | -$10.7M | -$7.1M | -$8.0M |
| Capital expenditures |
Get PHIO data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/PHIO/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/PHIO/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"